Global Peptide API CDMO Services Market Research Report 2025

Publication ID:

PB503259683

Publication Date:

March 14, 2025

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global market for Peptide API CDMO Services was valued at US$ 2342 million in the year 2024 and is projected to reach a revised size of US$ 6190 million by 2031, growing at a CAGR of 15.1% during the forecast period.
Peptide API CDMO (Contract Development and Manufacturing Organization) Services refer to the specialized services provided by companies that offer comprehensive support for the development, manufacturing, and production of peptide active pharmaceutical ingredients (APIs). These services are essential for the pharmaceutical and biotechnology industries, facilitating the production of peptides for therapeutic purposes.
Global key players of Peptide API CDMO Services include Bachem, PolyPeptide, CordenPharma, AmbioPharm, Thermo Fisher, etc. The top five players hold a share over 54%. North America is the largest market, and has a share about 52%, followed by Europe and China with share 33% and 9%, separately. In terms of product type, GMP Services is the largest segment, occupied for a share of 72%. In terms of application, Commercial has a share about 75 percent.
This report aims to provide a comprehensive presentation of the global market for Peptide API CDMO Services, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide API CDMO Services.
The Peptide API CDMO Services market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Peptide API CDMO Services market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Peptide API CDMO Services companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Chinese Peptide Company
ScinoPharm
ChengDu ShengNuo Biotec
CBL
Piramal Pharma
CPC Scientific
Segment by Type
GMP Services
Non-GMP Services
Segment by Application
Commercial
Scientific Research
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide API CDMO Services company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Peptide API CDMO Services Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 GMP Services
1.2.3 Non-GMP Services
1.3 Market by Application
1.3.1 Global Peptide API CDMO Services Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Commercial
1.3.3 Scientific Research
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Peptide API CDMO Services Market Perspective (2020-2031)
2.2 Global Peptide API CDMO Services Growth Trends by Region
2.2.1 Global Peptide API CDMO Services Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Peptide API CDMO Services Historic Market Size by Region (2020-2025)
2.2.3 Peptide API CDMO Services Forecasted Market Size by Region (2026-2031)
2.3 Peptide API CDMO Services Market Dynamics
2.3.1 Peptide API CDMO Services Industry Trends
2.3.2 Peptide API CDMO Services Market Drivers
2.3.3 Peptide API CDMO Services Market Challenges
2.3.4 Peptide API CDMO Services Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Peptide API CDMO Services Players by Revenue
3.1.1 Global Top Peptide API CDMO Services Players by Revenue (2020-2025)
3.1.2 Global Peptide API CDMO Services Revenue Market Share by Players (2020-2025)
3.2 Global Peptide API CDMO Services Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Peptide API CDMO Services Revenue
3.4 Global Peptide API CDMO Services Market Concentration Ratio
3.4.1 Global Peptide API CDMO Services Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Peptide API CDMO Services Revenue in 2024
3.5 Global Key Players of Peptide API CDMO Services Head office and Area Served
3.6 Global Key Players of Peptide API CDMO Services, Product and Application
3.7 Global Key Players of Peptide API CDMO Services, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Peptide API CDMO Services Breakdown Data by Type
4.1 Global Peptide API CDMO Services Historic Market Size by Type (2020-2025)
4.2 Global Peptide API CDMO Services Forecasted Market Size by Type (2026-2031)
5 Peptide API CDMO Services Breakdown Data by Application
5.1 Global Peptide API CDMO Services Historic Market Size by Application (2020-2025)
5.2 Global Peptide API CDMO Services Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Peptide API CDMO Services Market Size (2020-2031)
6.2 North America Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Peptide API CDMO Services Market Size by Country (2020-2025)
6.4 North America Peptide API CDMO Services Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Peptide API CDMO Services Market Size (2020-2031)
7.2 Europe Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Peptide API CDMO Services Market Size by Country (2020-2025)
7.4 Europe Peptide API CDMO Services Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Peptide API CDMO Services Market Size (2020-2031)
8.2 Asia-Pacific Peptide API CDMO Services Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Peptide API CDMO Services Market Size by Region (2020-2025)
8.4 Asia-Pacific Peptide API CDMO Services Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Peptide API CDMO Services Market Size (2020-2031)
9.2 Latin America Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Peptide API CDMO Services Market Size by Country (2020-2025)
9.4 Latin America Peptide API CDMO Services Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Peptide API CDMO Services Market Size (2020-2031)
10.2 Middle East & Africa Peptide API CDMO Services Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Peptide API CDMO Services Market Size by Country (2020-2025)
10.4 Middle East & Africa Peptide API CDMO Services Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Bachem
11.1.1 Bachem Company Details
11.1.2 Bachem Business Overview
11.1.3 Bachem Peptide API CDMO Services Introduction
11.1.4 Bachem Revenue in Peptide API CDMO Services Business (2020-2025)
11.1.5 Bachem Recent Development
11.2 PolyPeptide
11.2.1 PolyPeptide Company Details
11.2.2 PolyPeptide Business Overview
11.2.3 PolyPeptide Peptide API CDMO Services Introduction
11.2.4 PolyPeptide Revenue in Peptide API CDMO Services Business (2020-2025)
11.2.5 PolyPeptide Recent Development
11.3 CordenPharma
11.3.1 CordenPharma Company Details
11.3.2 CordenPharma Business Overview
11.3.3 CordenPharma Peptide API CDMO Services Introduction
11.3.4 CordenPharma Revenue in Peptide API CDMO Services Business (2020-2025)
11.3.5 CordenPharma Recent Development
11.4 AmbioPharm
11.4.1 AmbioPharm Company Details
11.4.2 AmbioPharm Business Overview
11.4.3 AmbioPharm Peptide API CDMO Services Introduction
11.4.4 AmbioPharm Revenue in Peptide API CDMO Services Business (2020-2025)
11.4.5 AmbioPharm Recent Development
11.5 USV Peptides
11.5.1 USV Peptides Company Details
11.5.2 USV Peptides Business Overview
11.5.3 USV Peptides Peptide API CDMO Services Introduction
11.5.4 USV Peptides Revenue in Peptide API CDMO Services Business (2020-2025)
11.5.5 USV Peptides Recent Development
11.6 Thermo Fisher
11.6.1 Thermo Fisher Company Details
11.6.2 Thermo Fisher Business Overview
11.6.3 Thermo Fisher Peptide API CDMO Services Introduction
11.6.4 Thermo Fisher Revenue in Peptide API CDMO Services Business (2020-2025)
11.6.5 Thermo Fisher Recent Development
11.7 Bio Basic
11.7.1 Bio Basic Company Details
11.7.2 Bio Basic Business Overview
11.7.3 Bio Basic Peptide API CDMO Services Introduction
11.7.4 Bio Basic Revenue in Peptide API CDMO Services Business (2020-2025)
11.7.5 Bio Basic Recent Development
11.8 JPT
11.8.1 JPT Company Details
11.8.2 JPT Business Overview
11.8.3 JPT Peptide API CDMO Services Introduction
11.8.4 JPT Revenue in Peptide API CDMO Services Business (2020-2025)
11.8.5 JPT Recent Development
11.9 Genscript
11.9.1 Genscript Company Details
11.9.2 Genscript Business Overview
11.9.3 Genscript Peptide API CDMO Services Introduction
11.9.4 Genscript Revenue in Peptide API CDMO Services Business (2020-2025)
11.9.5 Genscript Recent Development
11.10 Chinese Peptide Company
11.10.1 Chinese Peptide Company Company Details
11.10.2 Chinese Peptide Company Business Overview
11.10.3 Chinese Peptide Company Peptide API CDMO Services Introduction
11.10.4 Chinese Peptide Company Revenue in Peptide API CDMO Services Business (2020-2025)
11.10.5 Chinese Peptide Company Recent Development
11.11 ScinoPharm
11.11.1 ScinoPharm Company Details
11.11.2 ScinoPharm Business Overview
11.11.3 ScinoPharm Peptide API CDMO Services Introduction
11.11.4 ScinoPharm Revenue in Peptide API CDMO Services Business (2020-2025)
11.11.5 ScinoPharm Recent Development
11.12 ChengDu ShengNuo Biotec
11.12.1 ChengDu ShengNuo Biotec Company Details
11.12.2 ChengDu ShengNuo Biotec Business Overview
11.12.3 ChengDu ShengNuo Biotec Peptide API CDMO Services Introduction
11.12.4 ChengDu ShengNuo Biotec Revenue in Peptide API CDMO Services Business (2020-2025)
11.12.5 ChengDu ShengNuo Biotec Recent Development
11.13 CBL
11.13.1 CBL Company Details
11.13.2 CBL Business Overview
11.13.3 CBL Peptide API CDMO Services Introduction
11.13.4 CBL Revenue in Peptide API CDMO Services Business (2020-2025)
11.13.5 CBL Recent Development
11.14 Piramal Pharma
11.14.1 Piramal Pharma Company Details
11.14.2 Piramal Pharma Business Overview
11.14.3 Piramal Pharma Peptide API CDMO Services Introduction
11.14.4 Piramal Pharma Revenue in Peptide API CDMO Services Business (2020-2025)
11.14.5 Piramal Pharma Recent Development
11.15 CPC Scientific
11.15.1 CPC Scientific Company Details
11.15.2 CPC Scientific Business Overview
11.15.3 CPC Scientific Peptide API CDMO Services Introduction
11.15.4 CPC Scientific Revenue in Peptide API CDMO Services Business (2020-2025)
11.15.5 CPC Scientific Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer

Companies Mentioned:

Bachem
PolyPeptide
CordenPharma
AmbioPharm
USV Peptides
Thermo Fisher
Bio Basic
JPT
Genscript
Chinese Peptide Company
ScinoPharm
ChengDu ShengNuo Biotec
CBL
Piramal Pharma
CPC Scientific

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂